Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
32.56
-0.50 (-1.51%)
Jul 21, 2026, 4:08 PM HKT

HKG:3692 Stock Forecast

Stock Price Forecast

According to 22 analysts polled by S&P Global, HKG:3692 stock has a consensus rating of "Strong Buy" and an average price target of $46.60. The average 1-year stock price forecast is 43.12% higher than the current stock price, while the lowest is $38.83 (+19.26%) and the highest is $52.90 (+62.47%).

Price Target: $46.60 (+43.12%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$38.83$46.60$46.36$52.90
Change+19.26%+43.12%+42.38%+62.47%

Analyst Ratings

The average analyst rating for HKG:3692 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJan '26Feb '26Mar '26Apr '26Jun '26Jul '26
Strong Buy191818161616
Buy455555
Hold111111
Sell111000
Strong Sell000000
Total252525222222

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Huatai Securities
No rating
Huatai Securities
Buy
Maintains
$44.68
BuyMaintains$44.68+37.22%Jul 16, 2026
Unknown Analyst
UBS
No rating
UBS
Buy
Maintains
$48.80
BuyMaintains$48.80+49.88%Jul 14, 2026
Unknown Analyst
Morgan Stanley
No rating
Morgan Stanley
Buy
Maintains
$45.00
BuyMaintains$45.00+38.21%Jul 14, 2026
Unknown Analyst
HSBC
No rating
HSBC
Buy
Maintains
$49.50
BuyMaintains$49.50+52.03%Jul 10, 2026
Unknown Analyst
Guosheng Securities
No rating
Guosheng Securities
Buy
Maintains
$40.61
BuyMaintains$40.61+24.72%Jun 19, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
16.94B
from 15.03B
Increased by 12.73%
Revenue Next Year
18.49B
from 16.94B
Increased by 9.15%
EPS This Year
0.99
from 0.93
Increased by 5.93%
EPS Next Year
1.07
from 0.99
Increased by 8.80%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
9.94B9.38B10.10B12.26B15.03B16.94B
Revenue Growth
14.33%-5.56%7.69%21.35%22.57%12.73%
Gross Profit
9.06B8.51B9.07B11.14B13.51B15.34B
Gross Margin
91.24%90.73%89.78%90.89%89.89%90.57%
Operating Income
2.82B2.61B2.68B3.90B5.40B6.10B
Net Income
2.71B2.58B3.28B4.37B5.56B5.92B
EPS
----0.930.99
EPS Growth
----27.40%5.93%
Forward PE
27.0924.9728.3124.0536.2928.52
Dividend / Share
0.070.090.190.320.390.36
Dividend Growth
-20.84%118.47%63.53%22.73%-7.73%
Free Cash Flow
1.26B1.45B2.07B2.40B5.16B5.57B
No. Analysts
-----22
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High17.5B
Avg16.9B
Low16.5B

Revenue Growth

Revenue Growth202620272028
High
16.1%
Avg
12.7%
Low
10.1%

EPS Forecast

EPS202620272028
High1.11
Avg0.99
Low0.90

EPS Growth

EPS Growth202620272028
High
18.8%
Avg
5.9%
Low
-3.2%